LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 24 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $17,915,000 | +54.6% | 9,820,000 | +40.3% | 0.00% | +50.0% |
| Q2 2017 | $11,585,000 | +211.0% | 7,000,000 | +180.0% | 0.00% | +100.0% |
| Q1 2017 | $3,725,000 | -1.3% | 2,500,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,775,000 | -11.9% | 2,500,000 | -13.6% | 0.00% | 0.0% |
| Q1 2016 | $4,286,000 | +2.9% | 2,895,000 | +8.3% | 0.00% | 0.0% |
| Q4 2015 | $4,165,000 | -9.4% | 2,673,000 | -23.6% | 0.00% | 0.0% |
| Q3 2015 | $4,597,000 | – | 3,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 41,855,000 | $69,957,000 | 3.06% |
| Myriad Asset Management Ltd. | 20,000,000 | $33,349,000 | 2.89% |
| TFG Asset Management GP Ltd | 6,000,000 | $10,022,000 | 2.28% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,425,000 | $14,058,000 | 2.18% |
| Opera Trading Capital | 3,700,000 | $6,178,000 | 1.34% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,575,000 | $37,644,000 | 1.29% |
| Man Investments (CH) AG | 1,000,000 | $1,668,000 | 0.87% |
| Verition Fund Management LLC | 3,200,000 | $5,352,000 | 0.68% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,445,000 | $40,849,000 | 0.62% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,800,000 | $8,014,000 | 0.29% |